As of 2026-09-12, the Relative Valuation of Landos Biopharma Inc (LABP) is (123.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.93 USD, the upside of Landos Biopharma Inc based on Relative Valuation is -639.8%.
The range of the Relative Valuation is (109.48) - (163.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 20.6x | 12.8x |
| Forward P/E multiples | 13.8x - 21.5x | 18.4x |
| Fair Price | (109.48) - (163.19) | (123.78) |
| Upside | -577.5% - -811.7% | -639.8% |
| Date | P/E |